BR112015012877A2 - composto de fórmula, composição farmacêutica, uso do composto e método para o tratamento do câncer - Google Patents
composto de fórmula, composição farmacêutica, uso do composto e método para o tratamento do câncerInfo
- Publication number
- BR112015012877A2 BR112015012877A2 BR112015012877A BR112015012877A BR112015012877A2 BR 112015012877 A2 BR112015012877 A2 BR 112015012877A2 BR 112015012877 A BR112015012877 A BR 112015012877A BR 112015012877 A BR112015012877 A BR 112015012877A BR 112015012877 A2 BR112015012877 A2 BR 112015012877A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- cancer treatment
- formula
- formula compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261732463P | 2012-12-03 | 2012-12-03 | |
| PCT/EP2013/075035 WO2014086667A1 (en) | 2012-12-03 | 2013-11-29 | Substituted isoxazole amine compounds as inhibitors of scd1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015012877A2 true BR112015012877A2 (pt) | 2018-04-24 |
Family
ID=49709654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015012877A BR112015012877A2 (pt) | 2012-12-03 | 2013-11-29 | composto de fórmula, composição farmacêutica, uso do composto e método para o tratamento do câncer |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9290465B2 (pt) |
| EP (1) | EP2925408A1 (pt) |
| JP (1) | JP2016501210A (pt) |
| KR (1) | KR20150091071A (pt) |
| CN (1) | CN104822420A (pt) |
| BR (1) | BR112015012877A2 (pt) |
| CA (1) | CA2890300A1 (pt) |
| HK (1) | HK1211863A1 (pt) |
| MX (1) | MX2015006930A (pt) |
| RU (1) | RU2015123276A (pt) |
| WO (1) | WO2014086667A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3529245A4 (en) | 2016-10-24 | 2020-12-23 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES OF THE LATEST |
| IL304017A (en) | 2017-01-06 | 2023-08-01 | Yumanity Therapeutics Inc | Methods for treating neurological disorders |
| CA3083000A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
| CN112724157B (zh) * | 2021-01-23 | 2022-04-19 | 中国科学院新疆理化技术研究所 | 二氢噁唑并[5,4-d]吡咯并[1,2-a]嘧啶-9(5H)-酮类衍生物及用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7919496B2 (en) * | 2004-09-20 | 2011-04-05 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes |
| EP2148878A4 (en) * | 2007-04-20 | 2011-08-10 | Merck Canada Inc | NEW HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME-A-DELTA-9-DESATURASE |
| WO2009073973A1 (en) * | 2007-12-11 | 2009-06-18 | Merck Frosst Canada Ltd. | Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
-
2013
- 2013-11-29 CN CN201380063224.0A patent/CN104822420A/zh active Pending
- 2013-11-29 EP EP13799270.7A patent/EP2925408A1/en not_active Withdrawn
- 2013-11-29 RU RU2015123276A patent/RU2015123276A/ru unknown
- 2013-11-29 KR KR1020157014612A patent/KR20150091071A/ko not_active Application Discontinuation
- 2013-11-29 CA CA2890300A patent/CA2890300A1/en not_active Abandoned
- 2013-11-29 US US14/443,849 patent/US9290465B2/en not_active Expired - Fee Related
- 2013-11-29 JP JP2015544468A patent/JP2016501210A/ja active Pending
- 2013-11-29 WO PCT/EP2013/075035 patent/WO2014086667A1/en active Application Filing
- 2013-11-29 MX MX2015006930A patent/MX2015006930A/es unknown
- 2013-11-29 BR BR112015012877A patent/BR112015012877A2/pt not_active Application Discontinuation
-
2015
- 2015-12-31 HK HK15112883.8A patent/HK1211863A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20150315160A1 (en) | 2015-11-05 |
| WO2014086667A1 (en) | 2014-06-12 |
| CN104822420A (zh) | 2015-08-05 |
| JP2016501210A (ja) | 2016-01-18 |
| KR20150091071A (ko) | 2015-08-07 |
| MX2015006930A (es) | 2015-09-08 |
| CA2890300A1 (en) | 2014-06-12 |
| HK1211863A1 (en) | 2016-06-03 |
| US9290465B2 (en) | 2016-03-22 |
| RU2015123276A (ru) | 2017-01-13 |
| EP2925408A1 (en) | 2015-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015004547A2 (pt) | compostos, composição farmacêutica, uso de um composto e método para o tratamento ou melhoria do cãncer | |
| CL2014002873A1 (es) | Compuestos derivados de pirimidin-amina o triazin-amina, inhibidores de adn-pk; composicion farmaceutica; y su uso para el tratamiento del cancer. | |
| BR112015002541A2 (pt) | composto, composição farmacêutica, uso de um composto, e, método para tratamento de hcv em um paciente. | |
| BR112015004489A2 (pt) | composto, composição farmacêutica, e, métodos para tratar um distúrbio proliferativo e para sintetizar um composto | |
| BR112014032105A2 (pt) | método para o tratamento de câncer | |
| DK2818482T3 (da) | Farmaceutisk sammensætning til behandling af cancer | |
| DK2824114T3 (da) | Farmaceutisk sammensætning til behandling af cancer | |
| BR112014032053A2 (pt) | composto, composição farmacêutica, utilização de um composto, método para o tratamento de câncer e invenção | |
| BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
| BR112012022879A2 (pt) | composto, composição farmacêutica, uso do composto e método de tratamento | |
| BR112012018951A2 (pt) | composição farmacêutica, combinação farmacêutica e método para o tratamento e\ou prevenção de um câncer e anticorpo | |
| BR112012018947A2 (pt) | composição farmacêutica para tratamento e\ou prevenção do cancêr | |
| BR112012022878A2 (pt) | composto, composição farmacêutica, uso do compostos e método de tratamento | |
| BR112014010179A2 (pt) | composto, composição farmacêutica, uso de um composto, e, método para a profilaxia ou tratamento de um estado ou condição | |
| BR112015001830A2 (pt) | composto, uso de um composto, método para o tratamento ou profilaxia de câncer e invenção | |
| BR112014028424A2 (pt) | compostos de pirimidina para o tratamento de câncer | |
| IL238662A (en) | Bandostatin derivatives, containing them and used to treat cancer | |
| BR112012026570A2 (pt) | composto, composição farmacêutica, uso de um composto, método para o tratamento de um indíviduo e produto combinado | |
| BR112015028115A2 (pt) | métodos e composições para o tratamento de câncer | |
| BR112014031896A2 (pt) | composto, composição farmacêutica, e, método para o tratamento de um distúrbio | |
| BR112014009889A2 (pt) | compostos dissubstituídos, compostos e composição farmacêutica | |
| BR112015000649A2 (pt) | compostos, composição farmacêutica, uso de um composto, método para tratar ou melhorar câncer e invenção | |
| BR112015006512A2 (pt) | composição para tratar tecidos biológicos danificados | |
| BR112014016736A2 (pt) | composto, composição farmacêutica, método para tratamento, uso de um composto e invenção | |
| BR112014031512A2 (pt) | composição cosmética e método para o tratamento cosmético. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |